Xiamen Amoytop Biotech Co., Ltd. (SHSE: 688278)
Health Care · Biotechnology · CN
CN¥52.89
+2.90% today · -35.0% 1Y
Xiamen Amoytop Biotech Co., Ltd. (SHSE: 688278) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.13B and employs 3,640 people.
Over the last twelve months the share price has lost 35.0%, trading between 48.88 and 89.65.
Tweenvest scores Xiamen Amoytop Biotech Co., Ltd. across four factors: quality 87/100, value 80/100, growth 100/100, dividend 17/100. Its strongest factor is growth.
688278 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.13B
- Revenue (TTM)
- $592.03M
- P/E
- 20.12
- EPS
- 2.63
- Dividend yield
- 1.17%
- Beta (5Y)
- -0.15
- 52-week high
- CN¥89.65
- 52-week low
- CN¥48.88
- Avg volume (3M)
- —
- Shares outstanding
- 397.44M
- Employees
- 3,640
- Next earnings
- —
About Xiamen Amoytop Biotech Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd. specializes in the creation, commercialization, and distribution of biopharmaceutical products within China, utilizing advanced genetic engineering techniques. Its offerings span a variety of pharmaceutical goods, including finished drug formulations, diagnostic reagents, and active pharmaceutical ingredients (APIs). The company further extends its services to include bespoke contract manufacturing. Founded in 1996, the firm is headquartered in Xiamen, China.
- ISIN
- CNE100003RT3
- Founded
- 1996
- Listed since
- Jan 17, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Acadia Pharmaceuticals Inc.NasdaqGS: ACAD | $3.39B | $19.46 | -0.99% |
| Viking Therapeutics, Inc.NasdaqCM: VKTX | $3.33B | $28.41 | -0.47% |
| CareDx, Inc.NasdaqGM: CDNA | $3.26B | $62.94 | -0.16% |
| Evopoint Biosciences Co., Ltd.SHSE: 688837 | $3.21B | CN¥49.40 | 0.00% |
| Arcus Biosciences, Inc.NYSE: RCUS | $3.12B | $24.52 | +0.99% |
| Denali Therapeutics Inc.NasdaqGS: DNLI | $3.06B | $19.00 | -0.84% |
| Precigen, Inc.NasdaqGS: PGEN | $3.06B | $7.50 | -12.18% |
| Arcutis Biotherapeutics, Inc.NasdaqGS: ARQT | $3.04B | $24.02 | -0.62% |
Figures last refreshed Oct 4, 2026.